ArticleAnnals of laboratory medicine2026
Enhancing Glomerular Hematuria Identification in Automated Urinalysis Using a Light Gradient Boosting Machine-Based Model: A Diagnostic Accuracy Study.
Article in Annals of laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glomerular hematuria (GH) is a key parameter assessed during urine analysis that is poorly identified using the automated UF-5000 system, which may misclassify GH and delay the detection of underlying glomerular diseases. We developed a light gradient boosting machine (LightGBM)-based model to improve GH detection using automated urinalysis data. Methods: We included 5,444 urine samples from patients with positive urinary occult blood results. All samples were manually classified into non-glomerular hematuria (NGH), GH, mixed hematuria, and non-hematuria groups, based on microscopic examination. We assessed 65 parameters using UF-5000 and UC-3500 analyzers and compared their performance with that of LightGBM, extreme gradient boosting, random forest, and logistic regression models. The final model was validated through 10-fold cross-validation with an independent test set and then compared with the performance of UF-5000. SHapley Additive exPlanations were applied to identify key predictive parameters. Results: Employing the LightGBM model substantially improved GH recognition accuracy to 44% during validation and 37% during testing (versus 16% and 11% achieved with the UF-5000 model, respectively). Sensitivity for GH increased from 0.3 in the UF-5000 model to 0.7 in the LightGBM model. A similar increasing trend was observed for the negative predictive value (0.6 to 0.9), accuracy (0.5 to 0.8), and Cohen's kappa agreement (0.4 to over 0.6). Key predictive parameters included red blood cell count, forward scatter peak in surface channel, and urinary protein level. Conclusions: This interpretable LightGBM-based model offers a substantial improvement in automated GH identification and is a promising tool for classifying hematuria sources.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.